Reply to van der Pluijm et al. Comment on “Weitzman et al. Resistance to Antimalarial Monotherapy Is Cyclic. J. Clin. Med. 2022, 11, 781”

Ortal Calfon-Peretz; Rachel Weitzman; Moshe Amitay; Abraham O. Samson

doi:10.3390/jcm11112972

Reply to van der Pluijm et al. Comment on “Weitzman et al. Resistance to Antimalarial Monotherapy Is Cyclic. J. Clin. Med. 2022, 11, 781”

Ortal Calfon-Peretz, Rachel Weitzman, Moshe Amitay, Abraham O. Samson

Bar-Ilan University - Azrieli Faculty of Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English
Article number	2972
Journal	Journal of Clinical Medicine
Volume	11
Issue number	11
DOIs	https://doi.org/10.3390/jcm11112972
State	Published - 25 May 2022

All Science Journal Classification (ASJC) codes

General Medicine

Access to Document

10.3390/jcm11112972

Cite this

@article{8f1e680a57a54f82bde0faab5b00b76f,

title = "Reply to van der Pluijm et al. Comment on “Weitzman et al. Resistance to Antimalarial Monotherapy Is Cyclic. J. Clin. Med. 2022, 11, 781”",

author = "Ortal Calfon-Peretz and Rachel Weitzman and Moshe Amitay and Samson, {Abraham O.}",

year = "2022",

month = may,

day = "25",

doi = "10.3390/jcm11112972",

language = "الإنجليزيّة",

volume = "11",

journal = "Journal of Clinical Medicine",

issn = "2077-0383",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "11",

}

TY - JOUR

T1 - Reply to van der Pluijm et al. Comment on “Weitzman et al. Resistance to Antimalarial Monotherapy Is Cyclic. J. Clin. Med. 2022, 11, 781”

AU - Calfon-Peretz, Ortal

AU - Weitzman, Rachel

AU - Amitay, Moshe

AU - Samson, Abraham O.

PY - 2022/5/25

Y1 - 2022/5/25

UR - http://www.scopus.com/inward/record.url?scp=85130792726&partnerID=8YFLogxK

U2 - 10.3390/jcm11112972

DO - 10.3390/jcm11112972

M3 - رسالة

C2 - 35683361

SN - 2077-0383

VL - 11

JO - Journal of Clinical Medicine

JF - Journal of Clinical Medicine

IS - 11

M1 - 2972

ER -

Reply to van der Pluijm et al. Comment on “Weitzman et al. Resistance to Antimalarial Monotherapy Is Cyclic. J. Clin. Med. 2022, 11, 781”

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this